Claims
- 1. A pharmaceutical composition for treating tumors selected from the group of bovine squamous cell carcinoma, bovine fibrosarcoma, equine sarcoid, equine melanoma, equine squamous cell carcinoma, canine mammary tumors, canine adenoma and canine melanoma, comprising an anti-tumor effective amount of a combination of an effective amount of a purified pyridine-soluble extract obtained from a microorganism selected from the group consisting of M. bovis BCG, M. phlei, M. smegmatis, M. kansasii, Nocardia rubra, Corynebacterium diphtheriae and Corynebacterium parvum, said extract obtained by:
- (a) preparing a whole cell paste of said microorganism;
- (b) washing said paste;
- (c) treating said paste with pyridine to produce an extract and a residue;
- (d) removing said pyridine from said extract; and
- (e) dialyzing said dried extract to obtain said purified pyridine-soluble extract, an effective amount of cell wall skeleton; and an effective amount of trehalose dimycolate; and a pharmaceutically acceptable carrier.
- 2. The composition of claim 1 wherein the amount of each of said pyridine-soluble extract and cell wall skeleton is up to about 40 milligrams and the amount of trehalose dimycolate is up to about 6 milligrams.
- 3. The composition of claim 1 wherein the composition is in lyophilized form.
- 4. The composition of claim 1 wherein the composition is in the form of an oil-droplet emulsion.
- 5. The composition of claim 2 wherein the amount of said pyridine-soluble extract product is between about 200 and about 5000 micrograms, the amount of cell wall skeleton is between about 50 and 2000 micrograms and the amount of trehalose dimycolate is between about 50 and 1000 micrograms.
- 6. A method of treating tumors selected from the group consisting of bovine squamous cell carcinoma, bovine fibrosarcoma, equine sarcoid, equine melanoma, equine squamous cell carcinoma, canine mammary tumors, canine adenoma and canine melanoma in warm blooded animals comprising administering an effective amount of the composition of claim 1 to said warm blooded animals by injection directly into the tumor.
- 7. The method of claim 6 further comprising injecting into said tumor said composition containing between about 375 and 2500 micrograms/milliliters of said pyridine-soluble extract product and between about 125 and 375 micrograms/milliliters of each of said cell wall skeleton and trehalose dimycolate.
Parent Case Info
This application is a continuation of application Ser. No. 393,822, filed June 30, 1982, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3956481 |
Jolles et al. |
May 1976 |
|
3976544 |
Adam et al. |
Aug 1976 |
|
Non-Patent Literature Citations (4)
Entry |
Meyer et al., J. Natl. Can. Inst., 52:103-108, 1974. |
Ribi et al., Natl. Can. Inst. Monograph, No. 39, 1974. |
Rozencweig et al., Canc., 40:334-342, 1977. |
Pharmacological Basis of Cancer Chemoth., Williams & Wilkins Co., 1975, pp. 245-270. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
393822 |
Jun 1982 |
|